Trade Castle Biosciences, Inc. - CSTL CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.39 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023346% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001124% | ||||||||
| Overnight fee time | 22:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 24.9 |
| Open | 25.63 |
| 1-Year Change | 33.7% |
| Day's Range | 25.29 - 26.77 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Jan 21, 2025 | 26.51 | 1.65 | 6.64% | 24.86 | 26.86 | 24.86 |
| Jan 17, 2025 | 24.74 | 0.08 | 0.32% | 24.66 | 25.36 | 23.94 |
| Jan 16, 2025 | 24.87 | 0.31 | 1.26% | 24.56 | 25.31 | 24.16 |
| Jan 15, 2025 | 24.82 | -0.89 | -3.46% | 25.71 | 26.29 | 24.46 |
| Jan 14, 2025 | 25.35 | -0.68 | -2.61% | 26.03 | 26.20 | 23.81 |
| Jan 13, 2025 | 25.95 | -2.90 | -10.05% | 28.85 | 29.65 | 24.48 |
| Jan 10, 2025 | 30.01 | -0.97 | -3.13% | 30.98 | 30.98 | 27.39 |
| Jan 8, 2025 | 32.50 | 1.03 | 3.27% | 31.47 | 32.63 | 30.55 |
| Jan 7, 2025 | 31.92 | 3.02 | 10.45% | 28.90 | 32.13 | 28.74 |
| Jan 6, 2025 | 29.26 | 1.19 | 4.24% | 28.07 | 30.30 | 27.59 |
| Jan 3, 2025 | 28.44 | 0.38 | 1.35% | 28.06 | 28.94 | 27.41 |
| Jan 2, 2025 | 27.97 | 1.54 | 5.83% | 26.43 | 28.08 | 26.43 |
| Dec 31, 2024 | 26.44 | -0.32 | -1.20% | 26.76 | 26.76 | 25.98 |
| Dec 30, 2024 | 26.46 | 0.26 | 0.99% | 26.20 | 26.66 | 25.57 |
| Dec 27, 2024 | 26.62 | -0.04 | -0.15% | 26.66 | 27.28 | 26.38 |
| Dec 26, 2024 | 26.93 | -0.47 | -1.72% | 27.40 | 27.53 | 26.71 |
| Dec 24, 2024 | 27.42 | 0.06 | 0.22% | 27.36 | 27.68 | 26.67 |
| Dec 23, 2024 | 27.33 | -0.12 | -0.44% | 27.45 | 27.62 | 26.94 |
| Dec 20, 2024 | 27.44 | 1.28 | 4.89% | 26.16 | 27.84 | 26.15 |
| Dec 19, 2024 | 26.95 | 0.51 | 1.93% | 26.44 | 27.12 | 26.27 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Castle Biosciences Inc. Company profile
About Castle Biosciences Inc
Castle Biosciences, Inc. is a commercial-stage dermatological cancer company. The Company provides physicians and their patients with personalized, clinically actionable genomic information to make more accurate treatment decisions. The Company markets its three dermatologic products, DecisionDx-Melanoma, DecisionDx-SCC and DecisionDx DiffDx-Melanoma. It also market DecisionDx-UM, a gene expression profiling (GEP) test. It developed and market DecisionDx-Melanoma to healthcare providers for use with patients diagnosed with invasive cutaneous melanoma. It developed DecisionDx-SCC, a 40-gene expression profile test that uses an individual patient’s tumor biology to predict individual risk of squamous cell carcinoma metastasis for patients with one or more risk factors. It developed DecisionDx DiffDx-Melanoma, a GEP test designed to be used as an adjunct to histopathology when the distinction between a benign lesion and melanoma is uncertain.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Castle Biosciences Inc revenues increased 50% to $94.1M. Net loss increased from $10.3M to $31.3M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Higher net loss reflects Selling, General and Administrative. increase of 68% to $70.9M (expense), Research & Development - Balancing value increase from $11.7M to $24.9M (expense).
| Industry: | Laboratory Diagnostic & Testing Substances |
505 S Friendswood Drive
2014 San Miguel Dr
FRIENDSWOOD
TEXAS 77546
US
News
TRUMP coin ($TRUMP) price prediction: third-party price target
Read our TRUMP crypto price prediction for 2025 and beyond, with insights from third-party analysts and market experts
15:24, 21 January 2025
Ethereum price prediction: Third party data round up
What is the outlook for ETH as a long-term investment?
16:37, 7 January 2025
Euro forecast: third party data roundup
In 2024, the euro’s outlook appeared more stable. Read on for our 2025 and beyond insights.
12:40, 31 December 2024
Pi Network coin price prediction: Third party price target
Discover the Pi Network coin price predictions for 2025 onward, with analyst outlooks, price targets and CFDs trading strategies on Capital.com
13:51, 13 December 2024
Projected US interest rates in 5 years: Third party round up
As the US central bank starts its cutting cycle, what are the projected interest rates in 5 years?
14:28, 12 December 2024
Projected UK interest rates in 5 years
Bank of England (BoE) cut rates for the first time in August 2024, with further easing expected in the coming months. But how low are rates likely to go?
11:20, 12 December 2024
Dogecoin (DOGE) price prediction 2025-2030: Could Dogecoin reach $1? - Third party price target
We look at the meme coin’s price performance and the latest DOGE price predictions
08:37, 12 December 2024People also watch
Still looking for a broker you can trust?
Join the 680,000+ traders worldwide that chose to trade with Capital.com